What is Vericel's software and technology licenses, net?

Vericel (VCEL) reported software and technology licenses, net of $288K in Q1 2026.

How has Vericel's software and technology licenses, net changed year-over-year?

Vericel's software and technology licenses, net decreased by 42.5% year-over-year, from $501K to $288K.

Vericel VCEL Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

StrykerSYK

——

Zimmer Biomet HoldingsZBH

——

LeMaitre VascularLMAT

——

EnovisENOV

——

Globus MedicalGMED

——

Johnson & JohnsonJNJ

——

Other financials

Income statement

See full

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

See full

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

See full

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

See full

Market cap$2.13B-26.8%

Profitability

See full

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

See full

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vericel's software and technology licenses, net?: Vericel (VCEL) reported software and technology licenses, net of $288K in Q1 2026.
How has Vericel's software and technology licenses, net changed year-over-year?: Vericel's software and technology licenses, net decreased by 42.5% year-over-year, from $501K to $288K.